- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01250691
Effects of Isolated Rooms on the Prevalence of Hospital Acquired Pneumonia in a Respiratory ICU
November 30, 2010 updated by: Eskisehir Osmangazi University
Epidemiologic Study of Hospital Acquired Pneumonia in a Respiratory ICU
This study will carry out in the ICU.
Objectives of the study are to determine the frequency of HAP and the effect of isolated rooms on the frequency of pneumonia in the ICU.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In the present study, it was aimed to determine the incidence, causative agents, antimicrobial resistance, and risk factors for lower respiratory tract infections in patients followed in the ICU for the last 4 years.
The effect of reconfiguration from a ward-type ICU consisting one large room to an ICU with isolated rooms with two beds on the incidence of HAP was also determined.
Study Type
Observational
Enrollment (Actual)
532
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Eskisehir, Turkey, 26040
- Eskisehir Osmangazi University
-
-
Merkez
-
Eskisehir, Merkez, Turkey, 26040
- Eskisehir Osmangazi University
-
Eskisehir, Merkez, Turkey, 26040
- Osmangazi University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All of the patients who had been admitted to the ICU during this period were included in the study
Description
Inclusion Criteria:
- adult patients,
- admitted to the ICU
Exclusion Criteria:
- trauma, surgery or burned patients
- patients under 18
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
hospital acquired pneumonia
|
|
isolated rooms
|
frequency of hospital acquired pneumonia in the ICU
Other Names:
|
ward-type ICU
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Irfan Ucgun, As.Prof.Dr., Eskisehir Osmangazi University, Medical Faculty
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2004
Primary Completion (Actual)
July 1, 2008
Study Completion (Actual)
August 1, 2010
Study Registration Dates
First Submitted
November 30, 2010
First Submitted That Met QC Criteria
November 30, 2010
First Posted (Estimate)
December 1, 2010
Study Record Updates
Last Update Posted (Estimate)
December 1, 2010
Last Update Submitted That Met QC Criteria
November 30, 2010
Last Verified
January 1, 2004
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HAP-OU-isolation
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Biomedical Advanced Research and Development AuthorityNot yet recruitingHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
ShionogiCompletedHospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)Israel, Spain, United States, Belgium, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Japan, Latvia, Philippines, Puerto Rico, Russian Federation, Serbia, Taiwan, Ukraine
-
Avicenna Military HospitalCompletedHospital-acquired Pneumonia | Ventilator Associated Pneumonia | Community-acquired PneumoniaMorocco
Clinical Trials on ward-type ICU
-
University of California, DavisCompletedHead and Neck Cancer | Trauma | Head and Neck Squamous Cell Carcinoma | Head and Neck CarcinomaUnited States
-
University Hospital, AkershusHospital Pharmacy Enterprise, South Eastern NorwayUnknownIntensive Care Unit | Medicines ReconciliationNorway
-
Saint Savvas Anticancer HospitalUnknownPostoperative Care | Intensive CareGreece
-
University Hospital Bispebjerg and FrederiksbergRigshospitalet, DenmarkTerminated
-
Charite University, Berlin, GermanyLudwig-Maximilians - University of Munich; Technische Universität Berlin; BARMER and other collaboratorsCompleted
-
Ward Photonics LLCCompleted
-
Unity Health TorontoUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Canadian... and other collaboratorsUnknown
-
Brno University HospitalMasaryk University; Department of Neurology, University Hospital BrnoNot yet recruiting
-
Rigshospitalet, DenmarkBispebjerg HospitalRecruitingCancer | Chronic Obstructive Pulmonary Disease | Surgery-ComplicationsDenmark
-
Henry T. Stelfox, MD PhDCanadian Institutes of Health Research (CIHR); Alberta Health services; Canadian...CompletedCritical Illness | Transitions of CareCanada